Preparation method and application of a group of goat poxvirus recombinant protein antigens
A protein and antigen technology, applied in the field of molecular biotechnology and immunization, can solve the problems of immunity and safety defects, vaccines cannot be completely eliminated and controlled, etc., and achieve good antigen reactivity, no toxic side effects, and good immunogenicity Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0067] Embodiment 1, the preparation of goat pox subunit vaccine
[0068] 1. Preparation of ORF056-C, ORF112 and ORF117-C recombinant proteins
[0069] 1. Cloning of ORF056, ORF117 extracellular region and ORF112 gene and construction of expression vector
[0070] Genomic DNA of goat pox virus GTPV / HBSZ strain (recorded in the following documents: Zhou T, Jia H, Chen G, et al, Phylogenetic analysis of Chinese sheeppox and goatpox virus isolates. Virol J, 2012 9:25), PCR Amplify the extracellular region of ORF056 gene, the extracellular region fragment of ORF117 gene and the full length of ORF112 gene, digest the target fragment and prokaryotic expression vector with restriction endonuclease, connect the target gene and vector with ligase, and transform BL21 competent cells , the expression of the target protein is induced by an inducer, and the expressed protein is purified by a nickel chromatography column. details as follows:
[0071] 1), primer design and PCR amplificati...
Embodiment 2
[0110] Embodiment 2, recombinant protein antigen-specific antibody and neutralizing antibody assay
[0111] 1. Experimental animals and immunity
[0112] Seventy-two female BALB / C mice (18 g) aged 6-8 weeks were purchased from the Experimental Animal Center of Lanzhou University. Divided into 6 groups:
[0113] ORF056 recombinant protein vaccine group (GTPV-ORF056): The ORF056 recombinant protein vaccine in Example 1 was immunized by intramuscular injection into the legs of mice on 0d, 14d and 28d, with a dose of 200 μL (50 μg protein / mouse).
[0114] ORF112 recombinant protein vaccine group (GTPV-ORF112): The ORF112 recombinant protein vaccine prepared in Example 1 was immunized by intramuscular injection into the legs of mice on 0d, 14d and 28d, with a dose of 200 μL (50 μg protein / mouse).
[0115] ORF117 recombinant protein vaccine group (GTPV-ORF117): The ORF117 recombinant protein vaccine prepared in Example 1 was immunized by intramuscular injection into the legs of mi...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com